$ Value
$40K
Shares
15,980
Price
$2
Filed
Feb 3
Insider
Name
Loerop James
Title
Chief Business Officer
CIK
0001781549
Roles
Transaction Details
Transaction Date
2025-02-01
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
102,773
Footnotes
The transaction reported represents the withholding of shares by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units described in this Form 4. | This amendment is being filed to correct the number of shares that were withheld by the issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting and settlement of restricted stock units previously reported. This adjustment will affect the amount of securities beneficially owned following the reported transaction in subsequent filings.
Filing Info
Loerop James's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-03 | ACRS | M | — |
| 2026-02-03 | ACRS | F | $21K |
| 2026-02-03 | ACRS | M | $0 |
| 2026-02-02 | ACRS | A | $0 |
| 2026-02-02 | ACRS | A | $0 |
| 2026-02-01 | ACRS | M | — |
| 2026-02-01 | ACRS | M | — |
| 2026-02-01 | ACRS | M | — |
| 2026-02-01 | ACRS | F | $38K |
| 2026-02-01 | ACRS | M | $0 |
Other Insiders at ACRS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Walker Neal
CEO
|
— | — | 2026-02-03 |
|
Loerop James
Chief Business Officer
|
— | — | 2026-02-03 |
|
Balthaser Kevin
Chief Financial Officer
|
— | — | 2026-02-03 |
|
Davis Hugh M.
President and COO
|
— | — | 2026-02-03 |
|
Hall Jesse Wayne
Chief Medical Officer
|
— | — | 2026-02-02 |
|
Kolbeck Roland Wilhelm
Chief Scientific Officer
|
— | — | 2026-02-02 |